Plasma cell leukaemia
- PMID: 32258549
- PMCID: PMC6806952
- DOI: 10.1016/j.pbj.2016.04.001
Plasma cell leukaemia
Abstract
Plasma cell leukaemia (PCL) is a rare and aggressive disease. Diagnosis is made when there are >2000/#mL circulating plasma cells in peripheral blood or plasmacytosis >20% of total leukocyte count. We report a case of a 51-year old man with generalized bone pain and constitutional symptoms. Blood peripheral smear revealed leukocytosis with 39% plasma cells. Bone marrow biopsy showed plasma cell invasion, which confirmed the diagnosis of PCL. Additionally, the patient had markers of advanced disease. Chemotherapy with vincristine, adriamycin and dexamethasone was started. Despite an initial favourable response, the patient died 2 months later due to an infectious complication. PCL has no established treatment and has a dismal prognosis, requiring the achievement of better data to improve the disease course.
Keywords: Multiple myeloma; Plasma cell leukaemia.
Copyright 2016 PBJ-Associação Porto Biomedical/Porto Biomedical Society.
Conflict of interest statement
No conflict of interests was declared by the authors.
Figures
References
-
- Pagano L, Valentini CG, De Stefano V, Venditti a, Visani G, Petrucci MT, et al. Primary plasma cell leukemia: a retrospective multicenter study of 73 patients. Ann Oncol. 2011;22:1628-1635. - PubMed
-
- Kyle RA, Maldonado JE, Bayrd SD. Plasma cell leukemia. Report on 17 cases. Arch Intern Med. 1974;133:813-818. - PubMed
-
- Bladé J, Kyle RA. Nonsecretory myeloma immunoglobulin D myeloma, and plasma cell leukemia. Hematol Oncol Clin North Am. 1999;13:1259-1272. - PubMed
LinkOut - more resources
Full Text Sources